Mavacamten will lower the extent or result of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may lower systemic exposures of ethinyl estradiol and progestin, which can bring on contraceptive failure or a rise in breakthrough https://nielsone677oje2.wikitidings.com/user